ROBERT CONWAY Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT CONWAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT CONWAY. ROBERT CONWAY is Director in ARCA biopharma, Inc. ($ABIO) and CEO in ARRAY BIOPHARMA INC ($ARRY) and CHIEF EXECUTIVE OFFICER in ARRAY BIOPHARMA INC ($ARRY) and Director in Nivalis Therapeutics, Inc. ($NVLS).
Latest Insider Trading Transactions of ROBERT CONWAY
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ABIO, ARRY
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 3.19 | 10,000 | 31,947 | 50,000 | 40 K to 50 K (+25.00 %) |
| Jan 13 2021 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
| Dec 21 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.16 | 10,000 | 41,630 | 30,000 | 20 K to 30 K (+50.00 %) |
| Nov 23 2020 | ALPN | ALPINE IMMUNE SCIE ... | CONWAY ROBERT E | Director | Buy | P | 8.03 | 10,000 | 80,300 | 25,000 | 15 K to 25 K (+66.67 %) |
| Sep 25 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.28 | 5,000 | 21,400 | 20,000 | 15 K to 20 K (+33.33 %) |
| Sep 24 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.66 | 3,056 | 14,241 | 15,000 | 11.9 K to 15 K (+25.59 %) |
| Sep 21 2020 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 4.77 | 10,000 | 47,660 | 11,944 | 1.9 K to 11.9 K (+514.40 %) |
| Jan 06 2020 | ALPN | ALPINE IMMUNE SCIE ... | CONWAY ROBERT E | Director | Option Exercise | A | 3.62 | 7,650 | 27,718 | 7,650 | |
| Jan 04 2019 | ALPN | ALPINE IMMUNE SCIE ... | CONWAY ROBERT E | Director | Option Exercise | A | 4.09 | 7,650 | 31,289 | 7,650 | |
| Jan 04 2018 | NVLS | ALPINE IMMUNE SCIE ... | CONWAY ROBERT E | Director | Option Exercise | A | 11.31 | 7,650 | 86,522 | 7,650 | |
| Jul 17 2017 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 2.49 | 10,000 | 24,900 | 35,000 | 25 K to 35 K (+40.00 %) |
| May 11 2017 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Buy | P | 2.28 | 15,000 | 34,200 | 60,000 | 45 K to 60 K (+33.33 %) |
| May 10 2017 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Buy | P | 2.34 | 5,000 | 11,700 | 45,000 | 40 K to 45 K (+12.50 %) |
| May 09 2017 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Buy | P | 2.30 | 20,000 | 46,000 | 40,000 | 20 K to 40 K (+100.00 %) |
| May 08 2017 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Buy | P | 2.26 | 10,000 | 22,600 | 20,000 | 10 K to 20 K (+100.00 %) |
| Mar 27 2017 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Buy | P | 2.59 | 25,000 | 64,750 | 25,000 | 0 to 25 K |
| Feb 21 2017 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Option Exercise | A | 2.50 | 8,000 | 20,000 | 8,000 | |
| Sep 14 2016 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Option Exercise | A | 7.77 | 12,300 | 95,571 | 12,300 | |
| Feb 16 2016 | ABIO | ARCA biopharma, In ... | CONWAY ROBERT E | Director | Option Exercise | A | 3.44 | 8,000 | 27,520 | 8,000 | |
| Dec 11 2015 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Buy | P | 8.10 | 10,000 | 81,000 | 10,000 | 0 to 10 K |
| Sep 15 2015 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Option Exercise | A | 15.28 | 7,650 | 116,892 | 7,650 | |
| Jul 20 2015 | NVLS | Nivalis Therapeuti ... | CONWAY ROBERT E | Director | Option Exercise | A | 17.49 | 11,475 | 200,698 | 11,475 | |
| Oct 04 2011 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Grant | A | 0.00 | 57,190 | 0 | 633,386 | 576.2 K to 633.4 K (+9.93 %) |
| Jun 17 2011 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Buy | P | 2.17 | 25,000 | 54,250 | 576,196 | 551.2 K to 576.2 K (+4.54 %) |
| May 16 2011 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Buy | P | 2.86 | 20,000 | 57,200 | 551,196 | 531.2 K to 551.2 K (+3.77 %) |
| Apr 05 2011 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | A | 3.06 | 100,000 | 306,000 | 100,000 | |
| Oct 06 2010 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Grant | A | 0.00 | 57,474 | 0 | 528,996 | 471.5 K to 529 K (+12.19 %) |
| Apr 01 2010 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | A | 2.74 | 100,000 | 274,000 | 100,000 | |
| Apr 01 2010 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Gift | G | 0.00 | 7,000 | 0 | 469,346 | 476.3 K to 469.3 K (-1.47 %) |
| Apr 01 2010 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Gift | G | 0.00 | 14,000 | 0 | 80,000 | 66 K to 80 K (+21.21 %) |
| Apr 01 2010 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Gift | G | 0.00 | 14,000 | 0 | 476,346 | 490.3 K to 476.3 K (-2.86 %) |
| Apr 01 2010 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Gift | G | 0.00 | 15,000 | 0 | 66,000 | 51 K to 66 K (+29.41 %) |
| Apr 01 2010 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Gift | G | 0.00 | 15,000 | 0 | 490,346 | 505.3 K to 490.3 K (-2.97 %) |
| Oct 13 2009 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | M | 0.60 | 228,751 | 137,251 | 0 | |
| Oct 13 2009 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Payment of Exercise | F | 2.58 | 125,324 | 323,336 | 505,346 | 630.7 K to 505.3 K (-19.87 %) |
| Oct 13 2009 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Buy | M | 0.60 | 228,751 | 137,251 | 630,670 | 401.9 K to 630.7 K (+56.91 %) |
| Oct 06 2009 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Grant | A | 0.00 | 50,532 | 0 | 401,919 | 351.4 K to 401.9 K (+14.38 %) |
| May 01 2009 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | A | 3.01 | 100,000 | 301,000 | 100,000 | |
| Sep 11 2008 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | A | 6.22 | 100,000 | 622,000 | 100,000 | |
| Apr 17 2008 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | M | 0.60 | 51,249 | 30,749 | 228,751 | |
| Apr 17 2008 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Buy | M | 0.60 | 51,249 | 30,749 | 349,931 | 298.7 K to 349.9 K (+17.16 %) |
| Apr 17 2008 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Gift | G | 0.00 | 6,000 | 0 | 298,682 | 304.7 K to 298.7 K (-1.97 %) |
| Apr 11 2008 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | M | 0.60 | 20,000 | 12,000 | 280,000 | |
| Apr 11 2008 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Buy | M | 0.60 | 20,000 | 12,000 | 304,682 | 284.7 K to 304.7 K (+7.03 %) |
| Apr 11 2008 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Gift | G | 0.00 | 5,000 | 0 | 284,063 | 289.1 K to 284.1 K (-1.73 %) |
| Dec 21 2007 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | M | 0.60 | 10,000 | 6,000 | 300,000 | |
| Dec 21 2007 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Buy | M | 0.60 | 10,000 | 6,000 | 289,063 | 279.1 K to 289.1 K (+3.58 %) |
| Nov 16 2007 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | M | 0.60 | 10,000 | 6,000 | 310,000 | |
| Nov 16 2007 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Buy | M | 0.60 | 10,000 | 6,000 | 279,063 | 269.1 K to 279.1 K (+3.72 %) |
| Aug 08 2005 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 6.51 | 400,000 | 2,604,000 | 400,000 | |
| Aug 08 2005 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CHIEF EXECUTIVE OFF ... | Gift | G | 0.00 | 6,000 | 0 | 199,071 | 205.1 K to 199.1 K (-2.93 %) |
| Aug 03 2004 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 6.68 | 17,337 | 115,811 | 17,337 | |
| Aug 03 2004 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CHIEF EXECUTIVE OFF ... | Gift | G | 0.00 | 8,000 | 0 | 204,500 | 212.5 K to 204.5 K (-3.76 %) |
Page: 1